Concepedia

Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series: Case Report

Bingnan Zhang, Komal Shah, Kaiwen Wang, Eric K. Singhi, Whitney E. Lewis, Melvin J. Rivera, Mehmet Altan, J.V. Pozadzides, Xiuning Le, Natalie I. Vokes,

Journal of Thoracic Oncology · 2025 · 16 citations · 4 references

DOIFull text

Open access

Concepts

References

4

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

Myung‐Ju Ahn, Byoung Chul Cho, Enriqueta Felip et al. · New England Journal of Medicine · 2023 · 482 citations

, , +16

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study

Luis Paz‐Ares, Stéphane Champiat, W. Victoria Lai et al. · Journal of Clinical Oncology · 2023 · 294 citations · Full text

, , +17

Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update

Afshin Dowlati, Horst-Dieter Hummel, Stéphane Champiat et al. · Journal of Clinical Oncology · 2024 · 51 citations · Full text

, , +17

Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms

Alejandra G. Serrano, Pedro Rocha, Cibelle Freitas Lima et al. · npj Precision Oncology · 2024 · 28 citations · Full text

, , +15